LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Clinical trials for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER NON-SMALL CELL CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to control advanced lung cancer
Disease control Recruiting nowThis study tests whether combining two types of drugs (EGFR-TKIs and a PD-1 antibody) can help control advanced non-small cell lung cancer with specific EGFR mutations. It involves 32 adults who have not had prior treatment. The main goal is to see how long the cancer stays under…
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New lung cancer combo shows promise in early trial
Disease control Recruiting nowThis study tests whether giving immunotherapy and chemotherapy before surgery or radiation, followed by more immunotherapy, can help people with stage III lung cancer live longer without the cancer coming back. About 176 adults with resectable or borderline resectable non-small c…
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: PHASE2 • Sponsor: University Hospital, Bonn • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC